Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder.

Yan, Tingjian; Greene, Mallik; Chang, Eunice; Houle, Christy R; Tarbox, Marian H; Broder, Michael S

Yan, Tingjian; Greene, Mallik; Chang, Eunice; Houle, Christy R; Tarbox, Marian H; Broder, Michael S.

Afiliación

Yan T; Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, USA.
Greene M; Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, 08540, USA.
Chang E; Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, USA.
Houle CR; Lundbeck, Deerfield, IL 60015, USA.
Tarbox MH; Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, USA.
Broder MS; Partnership for Health Analytic Research, LLC, Beverly Hills, CA 90212, USA.

Clinicoecon Outcomes Res ; 12: 81-89, 2020.

Article en En | MEDLINE | ID: mdl-32104020

Palabras clave

adjunctive therapy; atypical antipsychotics; healthcare utilization; major depressive disorder; psychiatric cost

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_financiamento_saude Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clinicoecon Outcomes Res Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google